320
Views
15
CrossRef citations to date
0
Altmetric
HER2 Upregulates hTERT in Irradiated Breast Cancer Cells

hTERT regulation by NF-κB and c-myc in irradiated HER2-positive breast cancer cells

, , , , , , & show all
Pages 609-621 | Received 24 Jun 2010, Accepted 11 Mar 2011, Published online: 01 Jun 2011

References

  • Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, Sato M, Sato N. 2005. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Research 65:11018–11025.
  • Baud V, Karin M. 2009. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nature Reviews Drug Discovery 8:33–40.
  • Cosgrave N, Hill AD, Young LS. 2006. Growth factor-dependent regulation of survivin by c-myc in human breast cancer. Journal of Molecular Endocrinology 37:377–390.
  • Flint J, Craddock CF, Villegas A, Bentley DP, Williams HJ, Galanello R, Cao A, Wood WG, Ayyub H, Higgs DR. 1994. Healing of broken human chromosomes by the addition of telomeric repeats. American Journal of Human Genetics 55:505–512.
  • Fujiki T, Miura T, Maura M, Shiraishi H, Nishimura S, Imada Y, Uehara N, Tashiro K, Shirahata S, Katakura Y. 2007. TAK1 represses transcription of the human telomerase reverse transcriptase gene. Oncogene 26:5258–5266.
  • Gee JM, Nicholson RI. 2003. Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: Radiosensitization. Breast Cancer Research 5:126–129.
  • Goueli BS, Janknecht R. 2004. Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2/Neu, Ras, or Raf. Molecular and Cellular Biology 24:25–35.
  • Horikawa I, Barrett JC. 2003. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24:1167–1176.
  • Hynes NE, Stern DF. 1994. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochimica et Biophysica Acta 1198:165–184.
  • Jameel JK, Rao VS, Cawkwell L, Drew PJ. 2004. Radioresistance in carcinoma of the breast. Breast 13:452–460.
  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. 2009. Cancer statistics, 2009. CA: A Cancer Journal for Clinicians 59:225–249.
  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015.
  • Kyo S, Inoue M. 2002. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy? Oncogene 21:688–697.
  • Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A, Inoue M. 1999. Estrogen activates telomerase. Cancer Research 59:5917–5921.
  • Liang K, Lu Y, Jin W, Ang KK, Milas L, Fan Z. 2003. Sensitization of breast cancer cells to radiation by trastuzumab. Molecular Cancer Therapeutics 2:1113–1120.
  • Lin Z, Lim S, Viani MA, Sapp M, Lim MS. 2001. Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents. American Journal of Pathology 159:711–719.
  • Pandita TK, Roti Roti JL. 2003. Role of telomerase in radiocurability (Review). Oncology Reports 10:263–270.
  • Papanikolaou V, Iliopoulos D, Dimou I, Dubos S, Tsougos I, Theodorou K, Kitsiou-Tzeli S, Tsezou A. 2009. The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells. International Journal of Oncology 35:1141–1149.
  • Satra M, Tsougos I, Papanikolaou V, Theodorou K, Kappas C, Tsezou A. 2006. Correlation between radiation-induced telomerase activity and human telomerase reverse transcriptase mRNA expression in HeLa cells. International Journal of Radiation Biology 82:401–409.
  • Sawant SG, Gregoire V, Dhar S, Umbricht CB, Cvilic S, Sukumar S, Pandita TK. 1999. Telomerase activity as a measure for monitoring radiocurability of tumor cells. Faseb Journal 13:1047–1054.
  • Sethi G, Ahn KS, Aggarwal BB. 2008. Targeting nuclear factor-kappa B activation pathway by thymoquinone: Role in suppression of antiapoptotic gene products and enhancement of apoptosis. Molecular Cancer Research 6:1059–1070.
  • Shay JW, Bacchetti S. 1997. A survey of telomerase activity in human cancer. European Journal of Cancer 33:787–791.
  • Tsezou A, Oikonomou P, Kollia P, Mademtzis I, Kostopoulou E, Messinis I, Vamvakopoulos N. 2005. The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias. Experimental Biology and Medicine (Maywood) 230:263–270.
  • Wang Z, Kyo S, Takakura M, Tanaka M, Yatabe N, Maida Y, Fujiwara M, Hayakawa J, Ohmichi M, Koike K, et al. 2000. Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway. Cancer Research 60:5376–5381.
  • Wilkie AO, Lamb J, Harris PC, Finney RD, Higgs DR. 1990. A truncated human chromosome 16 associated with alpha thalassaemia is stabilized by addition of telomeric repeat (TTAGGG)n. Nature 346: 868–871.
  • Xu D, Popov N, Hou M, Wang Q, Bjorkholm M, Gruber A, Menkel AR, Henriksson M. 2001. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proceedings of the National Academy of Sciences of the USA 98:3826–3831.
  • Yarden Y. 2001. Biology of HER2 and its importance in breast cancer. Oncology 61(Suppl. 2):1–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.